Loading…
Back To Schedule
Monday, June 28 • 4:00pm - 5:00pm
#145 SL: Realizing the Value of Digital Biomarkers Across the Product Lifecycle

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Component Type: Forum
Level: Basic
CE: ACPE 1.00 Knowledge UAN: 0286-0000-21-549-L04-P; CME 1.00; IACET 1.00; RN 1.00

How should your organization be using digital biomarkers? Do you have a roadmap for digital biomarkers? This session will share examples of best practices of how digital biomarkers can be used to add value across the product lifecycle.

Learning Objectives

Demonstrate the basics of a digital biomarker and the value it can add to diagnostics and therapies across their lifecycle; Evaluate challenges in the development, deployment and reimbursement of digital biomarkers; Identify pathways to integrate digital biomarkers into their pipelines; Define the questions that organizations should answer before beginning digital biomarker development.

Chair

John Hall, PhD

Speaker

Panelist
Tim McCarthy, PhD, MBA

Panelist
Diane Stephenson, PhD

Panelist
Matthew Bonam

Panelist
Mo Ali


Speakers
MA

Mo Ali

Vice President, Digital Analytics and Performance, GlaxoSmithKline, United States
MB

Matthew Bonam

Global Head, BioPharma R&D Digital Health, AstraZeneca, United Kingdom
avatar for John Hall

John Hall

Head of Life Sciences, Huma, United Kingdom
John joined Huma as Head of Life Sciences in April 2020 and leads Huma's relationships with pharma companies across a portfolio of decentralized trial, digital biomarker and companion product solutions. John has over 20 years of experience in the life sciences industry. He spent his... Read More →
avatar for John Hall

John Hall

Head of Life Sciences, Huma, United Kingdom
John joined Huma as Head of Life Sciences in April 2020 and leads Huma's relationships with pharma companies across a portfolio of decentralized trial, digital biomarker and companion product solutions. John has over 20 years of experience in the life sciences industry. He spent his... Read More →
avatar for Tim McCarthy

Tim McCarthy

Head, Digital Medicine and Translational Imaging, Pfizer Inc, United States
Tim leads the Digital Medicine & Translational Imaging group at Pfizer. This team is dedicated to applying sensor- and non-invasive imaging-based technologies to clinical development programs across the Pfizer enterprise. He has a background in Positron Emission Tomography which he... Read More →
avatar for Diane Stephenson

Diane Stephenson

Executive Director, Critical Path Institute, United States
Diane Stephenson is a neuroscientist by training with 30 years combined experience in academic neuroscience and drug discovery. Dr. Stephenson received her undergraduate degree in Biochemistry at University of California and her Ph.D. in Medical Neurobiology from Indiana University... Read More →

Monday June 28, 2021 4:00pm - 5:00pm EDT
TBD Virtual Event Horsham, PA 19044
  03: Data-Data Standards, Forum |   02: ClinTrials -ClinOps, Forum